CLPT
Clearpoint Neuro Inc
11.50$
+5.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.2% | -17.2% | -50.3% | -34.0% | -14.8% | -16.0% | -72.7% | -27.7% | -35.2% | -116.0% | -65.7% | -64.5% | -71.4% | |
| 7.3% | 6.2% | 6.2% | 5.9% | -2.4% | 6.1% | 3.9% | 6.8% | 4.8% | -3.9% | 9.2% | 6.0% | 4.2% | |
| 27.5% | 22.7% | 19.7% | 22.9% | 23.4% | 21.9% | 22.5% | 24.6% | 22.8% | 19.0% | 18.3% | 20.9% | 20.1% | |
| 9.4% | 16.3% | -20.2% | -2.2% | 21.1% | 22.6% | -30.7% | 2.1% | -0.4% | -70.8% | -18.3% | -6.1% | -24.3% | |
| 4.1% | 2.8% | 0.0% | 0.0% | 0.1% | 3.4% | 2.2% | 1.0% | 2.2% | 0.5% | 5.3% | 2.0% | 2.6% | |
| -4.1% | -2.8% | – | – | -0.1% | -3.4% | -2.2% | -1.0% | -2.2% | 10.5% | -5.3% | -2.0% | 0.1% | |
| -1.6% | -0.5% | -2.0% | 3.7% | -0.8% | 0.1% | – | 3.4% | – | – | – | 5.0% | – | |
| – | – | – | – | – | 0.0% | – | – | – | 186.7% | – | – | – | |
| -1.6% | 2.3% | 210.1% | 2.0% | -123.9% | 0.5% | -16.1% | 347.0% | 0.0% | 187.9% | -15.2% | 9.2% | 44.3% | |
| -36.8% | -17.7% | 159.9% | -31.9% | -138.8% | -18.9% | -90.9% | 318.3% | -37.5% | 82.3% | -85.2% | -57.2% | -26.7% | |
| -35.2% | -19.9% | -50.3% | -34.0% | -14.9% | -19.4% | -74.9% | -28.7% | -37.5% | -116.5% | -71.0% | -66.4% | -74.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.